36017130|t|Scutellarin Loaded on Ultradeformable Nanoliposome Scutellarin EDTMP (S-UNL-E) Promotes Osteogenesis in Osteoporotic Rats.
36017130|a|Scutellarin is known as a safe, effective, and low-cost traditional Chinese medicine and has a variety of biological activities. Studies reported that the scutellarin loaded on ultradeformable nanoliposome scutellarin EDTMP (S-UNL-E) could promote osteoblast differentiation and bone formation in vitro. However, its effect on promoting osteogenesis in vivo is still unclear. In this study, pharmacology network and transcriptome sequencing were used to screen the potential targets and pathways of scutellarin in treating osteoporosis. The female Sprague-Dawley (SD) rats were operated on with bilateral oophorectomy and femoral defect to establish an osteoporosis model and then treated separately with bone dust, single scutellarin, 40 mg/kg ultradeformable nanoliposome scutellarin (S-UNL), and the optimal concentration of 40 mg/kg S-UNL-E for a total of 56 d to detect the parameters of trabecular bones. And qRT-PCR and western blot were performed to determine the expression of prostaglandin-endoperoxide synthase 2 (PTGS2), alkaline phosphatase (ALP), transcription factor 4 (TCF4), and beta-catenin. Results of microscopic computed tomography (Micro-CT) of trabecular bones showed that single scutellarin, S-UNL, and S-UNL-E all promoted the bone formation of osteoporotic rats, in which S-UNL-E manifested the most remarkable therapeutic effect. And it is found that 40 mg/kg of S-UNL-E increased the expression of PTGS2, ALP, TCF4, and beta-catenin, which indicated that S-UNL-E stimulated the secretion of ALP in bone defect areas to promote bone healing, and increased PTGS2 expression thereby enhancing the transcription and translation of key gene beta-catenin and TCF4 in the Wnt/beta-catenin signaling pathway to treat osteoporotic rats.
36017130	22	62	Ultradeformable Nanoliposome Scutellarin	Chemical	-
36017130	70	77	S-UNL-E	Chemical	-
36017130	104	116	Osteoporotic	Disease	MESH:D058866
36017130	117	121	Rats	Species	10116
36017130	191	207	Chinese medicine	Chemical	-
36017130	300	340	ultradeformable nanoliposome scutellarin	Chemical	-
36017130	348	355	S-UNL-E	Chemical	-
36017130	622	633	scutellarin	Chemical	MESH:C484876
36017130	646	658	osteoporosis	Disease	MESH:D010024
36017130	691	695	rats	Species	10116
36017130	728	740	oophorectomy	Disease	
36017130	745	759	femoral defect	Disease	MESH:D005266
36017130	776	788	osteoporosis	Disease	MESH:D010024
36017130	846	857	scutellarin	Chemical	MESH:C484876
36017130	868	908	ultradeformable nanoliposome scutellarin	Chemical	-
36017130	910	915	S-UNL	Chemical	-
36017130	960	967	S-UNL-E	Chemical	-
36017130	1109	1146	prostaglandin-endoperoxide synthase 2	Gene	29527
36017130	1148	1153	PTGS2	Gene	29527
36017130	1184	1206	transcription factor 4	Gene	84382
36017130	1208	1212	TCF4	Gene	84382
36017130	1219	1231	beta-catenin	Gene	84353
36017130	1339	1344	S-UNL	Chemical	-
36017130	1350	1357	S-UNL-E	Chemical	-
36017130	1393	1405	osteoporotic	Disease	MESH:D058866
36017130	1406	1410	rats	Species	10116
36017130	1421	1428	S-UNL-E	Chemical	-
36017130	1513	1520	S-UNL-E	Chemical	-
36017130	1549	1554	PTGS2	Gene	29527
36017130	1561	1565	TCF4	Gene	84382
36017130	1571	1583	beta-catenin	Gene	84353
36017130	1606	1613	S-UNL-E	Chemical	-
36017130	1649	1660	bone defect	Disease	MESH:D001847
36017130	1706	1711	PTGS2	Gene	29527
36017130	1787	1799	beta-catenin	Gene	84353
36017130	1804	1808	TCF4	Gene	84382
36017130	1816	1819	Wnt	Gene	114487
36017130	1820	1832	beta-catenin	Gene	84353
36017130	1860	1872	osteoporotic	Disease	MESH:D058866
36017130	1873	1877	rats	Species	10116
36017130	Negative_Correlation	MESH:C484876	MESH:D010024
36017130	Association	MESH:D058866	84382
36017130	Association	29527	84353
36017130	Association	MESH:D058866	84353
36017130	Association	MESH:D058866	114487

